Mary Jane Rotheram-Borus1, Emily Davis, Roxana Rezai. 1. Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, California, USA.
Abstract
PURPOSE OF REVIEW: Adolescents, in particular those that are most disenfranchised, are increasingly at risk of acquiring HIV and, when acquiring HIV, have worse outcomes than adults. This article reviews the recent approaches to combination prevention aiming to optimize the HIV prevention and HIV treatment continua. RECENT FINDINGS: There are dramatic sociodemographic differences in the HIV epidemics in low and middle-income countries (young women in sub-Saharan Africa) compared with high-income countries (predominantly gay, bisexual, transgendered youth, especially black and Latino youth). Researchers and clinicians are designing developmentally tailored interventions that anticipate youths' engagement with mobile technologies and build on the common features of evidence-based interventions that predate the use of antiretroviral therapies (ARV) for prevention and treatment. SUMMARY: Evidence-based HIV prevention and treatment programs that are cost-effective need to be broadly diffused globally. Substantial investments must be made in understanding how to implement programs, which have clinically meaningful impact and continuously monitor intervention quality over time.
PURPOSE OF REVIEW: Adolescents, in particular those that are most disenfranchised, are increasingly at risk of acquiring HIV and, when acquiring HIV, have worse outcomes than adults. This article reviews the recent approaches to combination prevention aiming to optimize the HIV prevention and HIV treatment continua. RECENT FINDINGS: There are dramatic sociodemographic differences in the HIV epidemics in low and middle-income countries (young women in sub-Saharan Africa) compared with high-income countries (predominantly gay, bisexual, transgendered youth, especially black and Latino youth). Researchers and clinicians are designing developmentally tailored interventions that anticipate youths' engagement with mobile technologies and build on the common features of evidence-based interventions that predate the use of antiretroviral therapies (ARV) for prevention and treatment. SUMMARY: Evidence-based HIV prevention and treatment programs that are cost-effective need to be broadly diffused globally. Substantial investments must be made in understanding how to implement programs, which have clinically meaningful impact and continuously monitor intervention quality over time.
Authors: Nithya Ramanathan; Dallas Swendeman; W Scott Comulada; Deborah Estrin; Mary Jane Rotheram-Borus Journal: Int J Med Inform Date: 2012-06-14 Impact factor: 4.046
Authors: M Isabel Fernández; Heather C Huszti; Patrick A Wilson; Shoshana Kahana; Sharon Nichols; René Gonin; Jiahong Xu; Bill G Kapogiannis Journal: AIDS Behav Date: 2015-05
Authors: Nadia Dowshen; Lisa M Kuhns; Amy Johnson; Brian James Holoyda; Robert Garofalo Journal: J Med Internet Res Date: 2012-04-05 Impact factor: 5.428
Authors: Linda B Mlunde; Krishna C Poudel; Bruno F Sunguya; Jessie K K Mbwambo; Junko Yasuoka; Keiko Otsuka; Omary Ubuguyu; Masamine Jimba Journal: BMC Public Health Date: 2012-12-09 Impact factor: 3.295
Authors: K Rivet Amico; Jessica Crawford; Ini Ubong; Jane C Lindsey; Aditya H Gaur; Keith Horvath; Rachel Goolsby; Megan Mueller Johnson; Ronald Dallas; Barbara Heckman; Teresa Filipowicz; Melissa Polier; Betty M Rupp; Michael Hudgens Journal: AIDS Patient Care STDS Date: 2021-05 Impact factor: 5.078
Authors: Makini A S Boothe; Cynthia Semá Baltazar; Isabel Sathane; Henry F Raymond; Erika Fazito; Marleen Temmerman; Stanley Luchters Journal: PLoS One Date: 2021-12-31 Impact factor: 3.240